Name: Alzheimer's Dementia: Dilemmas in Clinical Research (en Inglés)
Price: 189220.00 CLP
Availability: InStock
Author: Melnick, Vijaya L. ; Dubler, Nancy N.
ISBN: 9781461295976

portada Alzheimer's Dementia: Dilemmas in Clinical Research (en Inglés)

Formato

Libro Físico

Autor

Vijaya L. Melnick

Nancy N. Dubler

Editorial

Humana

Idioma

Inglés

N° páginas

312

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 1.8 cm

Peso

0.47 kg.

ISBN13

9781461295976

N° edición

Categorías

Desarrollos científicos y tecnológicos médicos
Ética médica y conducta profesional
Geriatría
Ciencias matemáticas

Alzheimer's Dementia: Dilemmas in Clinical Research (en Inglés)

Vijaya L. Melnick (Autor) · Nancy N. Dubler (Autor) · Humana · Tapa Blanda

Libro Nuevo

$ 189.220

$ 315.370

Ahorras: $ 126.150

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 07 de Junio y el Miércoles 19 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Alzheimer's Dementia: Dilemmas in Clinical Research (en Inglés)"

The National Institute on Aging (NIA) has historically been concerned with the protection of human subjects. In July 1977, the NIA sponsored a meeting to update and supplement guide- lines for protecting those participating in Federal research pro- jects. Although the basic guidelines had been in effect since 1966, it had been neglected to include the elderly as a vulnerable population. In November 1981, the NIA organized a conference on the ethical and legal issues related to informed consent in senile dementia cases. The present volume offers the latest and best thinking on Alzheimer's Dementia to have emerged from the dialog that was first embarked upon at the NIA meeting. Indeed, the issues and concerns it treats now seem even more relevant than they appeared historically because of the vastly greater awareness in the community of the entire spectrum of problems Alzheimer's disease confronts us all with. Our interest and concern is both humanitarian and self- serving. Clearly older people must be protected from in- appropriate research and careful attention must be paid to the circumstances under which research is conducted on those older persons who have given anything less than full consent. It is equally necessary, however, for the research enterprise to be protected so that today's elderly and those of the future can benefit from the fruits of research.